Dr Reddy's Labs assigns additional responsibilities of CHRO office to Sanjay Sharma

"We wish to inform that basis the recommendation of Nomination, Governance and Compensation Committee, the Board of Directors of the Company, at their meeting held today, i.e., October 24, 2025, have assigned additional responsibilities of CHRO’s office to Mr. Sanjay Sharma, Global Head Operations, and a Senior Management Personnel of the Company, effective from December 1, 2025," Dr Reddy's Labs stated in a BSE filing.

Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddy's Labs major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.